Merck's biosimilar to AbbVie's Humira wins FDA approval - CNA

Merck's biosimilar to AbbVie's Humira wins FDA approval  CNA

The U.S. Food and Drug Administration approved Merck & Co Inc's biosimilar to AbbVie Inc's blockbuster rheumatoid arthritis treatment Humira, the ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases